NCT06319924View on ClinicalTrials.gov

Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy

CompletedOBSERVATIONAL

Enrollment

601

Participants

Timeline

Start Date

February 1, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

September 15, 2022

Conditions

Colorectal CancerColonoscopyBowel Preparation Solution

Interventions

DRUG

Simethicone combined with Macrogol 4000 (PEG)

bowel preparation product for colonoscopy as part of CRC screening

Trial Locations (5)

13008

Saint Joseph Hospital, Marseille

31082

5. Clinique Ambroise Paré, Toulouse

31700

Clinique des Cèdres, Ramsay Santé,, Cornebarrieu

54280

Polyclinique Louis Pasteur,, Essey-lès-Nancy

70000

Pole Santé des Haberges, Vesoul

All Listed Sponsors

lead

Hospital St. Joseph, Marseille, France

OTHER

NCT06319924 - Fixed Low-dose Simethicone Combined With Macrogol 4000 (PEG) Reduces Colon Bubble Formation in Colonoscopy | Biotech Hunter | Biotech Hunter